Valuation: Jiangsu Hengrui Pharmaceuticals Co.,Ltd

Capitalization 420B 59.5B 50.69B 47.35B 44.55B 82.02B 5,389B 89.61B 553B 214B 2,540B 223B 219B 9,269B P/E ratio 2025 *
47.7x
P/E ratio 2026 * 43.2x
Enterprise value 381B 54B 46B 42.97B 40.43B 74.44B 4,891B 81.32B 502B 195B 2,306B 203B 198B 8,412B EV / Sales 2025 *
11.5x
EV / Sales 2026 * 10.1x
Free-Float
52.38%
Yield 2025 *
0.44%
Yield 2026 * 0.5%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.19%
1 week+2.69%
Current month+1.93%
1 month-0.44%
3 months-8.30%
6 months+17.42%
Current year+37.86%
More quotes
1 week 61.92
Extreme 61.92
64.15
1 month 59.31
Extreme 59.31
64.15
Current year 42.4
Extreme 42.4
74.04
1 year 42.4
Extreme 42.4
74.04
3 years 35.51
Extreme 35.51
74.04
5 years 27
Extreme 27
97.39
10 years 12.9
Extreme 12.9003
97.39
More quotes
Manager TitleAgeSince
Director of Finance/CFO 48 18/11/2021
President - 01/04/2025
Compliance Officer 33 31/05/2021
Director TitleAgeSince
Director/Board Member 55 15/01/2020
Director/Board Member 49 15/01/2020
Chairman 66 07/07/2021
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.19%+2.69%+35.82%+64.88% 59.5B
+1.80%+1.70%+30.21%+186.49% 920B
+0.75%+4.78%+44.31%+18.06% 510B
-0.29%-1.22%+28.81%+35.52% 395B
-0.35%+1.90%+25.12%+3.11% 340B
-1.12%-1.09%+28.43%+18.70% 278B
-0.45%-1.48%+20.24%+24.41% 254B
+1.30%+0.58%-1.67%-9.57% 249B
+0.45%+3.73%-57.41%-30.85% 224B
+0.11%-3.68%+17.41%+16.70% 171B
Average +0.20%+0.65%+17.13%+32.75% 340.15B
Weighted average by Cap. +0.53%+1.15%+22.11%+60.18%
See all sector performances

Financials

2025 *2026 *
Net sales 33.1B 4.69B 4B 3.73B 3.51B 6.47B 425B 7.06B 43.58B 16.9B 200B 17.6B 17.23B 731B 36.92B 5.23B 4.46B 4.16B 3.92B 7.21B 474B 7.88B 48.6B 18.85B 223B 19.63B 19.22B 815B
Net income 8.76B 1.24B 1.06B 988M 929M 1.71B 112B 1.87B 11.53B 4.47B 52.99B 4.66B 4.56B 193B 9.72B 1.38B 1.17B 1.1B 1.03B 1.9B 125B 2.07B 12.8B 4.96B 58.82B 5.17B 5.06B 215B
Net Debt -38.82B -5.5B -4.69B -4.38B -4.12B -7.58B -498B -8.29B -51.1B -19.82B -235B -20.64B -20.21B -857B -45.64B -6.47B -5.51B -5.15B -4.84B -8.92B -586B -9.74B -60.09B -23.31B -276B -24.27B -23.76B -1,008B
More financial data * Estimated data
Logo Jiangsu Hengrui Pharmaceuticals Co.,Ltd
Jiangsu Hengrui Medicine Co., Ltd. specializes in the research, development, manufacture and marketing of pharmaceutical products. The activity is organized primarily around 5 families of products: - anti-tumor drugs (No. 1 Chinese); - Anesthetic drugs; - contrast agents: used in medical imaging; - anti-inflammatory drugs; - drugs for the treatment of cardiovascular diseases.
Employees
20,238
More about the company
Date Price Change Volume
12/12/25 63.28 ¥ -0.19% 31,562,920
11/12/25 63.40 ¥ +0.03% 24,706,120
10/12/25 63.38 ¥ +0.48% 28,895,960
09/12/25 63.08 ¥ +0.99% 49,359,330
08/12/25 62.46 ¥ +1.36% 50,861,750

End-of-day quote Shanghai S.E., December 11, 2025

More quotes
Trader
Investor
Global
Quality
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
63.28CNY
Average target price
81.04CNY
Spread / Average Target
+28.06%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 600276 Stock